Skip to main content
logo
Cutia Therapeutics (HKG:2487)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.190
-0.010 (-0.83%)
Sep 21, 2026, 10:52 AM HKT

Cutia Therapeutics Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
332.58336.15279.62137.6211.372.04
Revenue Growth
-1.06%20.22%103.17%1110.83%457.70%-
Gross Profit
178.24195.79143.4671.017.941.61
Operating Income
-246.25-308.61-461.54-539.65-309.2-179.99
Net Income
-281.2-340.19-433.81-1,964-555.84-319.58
Earnings Per Share
-0.80-1.03-1.41-9.60-6.94-3.99
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
625.91788.24876.161,2731,0771,378
Total Debt
274.22317.39320.94243.762,6242,269
Net Cash (Debt)
351.69470.85555.221,029-1,548-891.19
Net Cash Growth
-25.31%-15.20%-46.04%---
Net Cash Per Share
1.001.421.815.03-19.33-11.13

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--290.09-442.98-381.31-236.19-159.88
Capital Expenditures
--11.69-22.57-55.73-134.35-24.32
Free Cash Flow
--301.79-465.56-437.04-370.54-184.2
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
53.59%58.25%51.31%51.60%69.84%79.00%
Operating Margin
-74.04%-91.81%-165.06%-392.13%-2720.43%-8831.45%
Pretax Margin
-83.80%-101.20%-155.15%-1426.91%-4890.34%-15681.11%
Profit Margin
-84.55%-101.20%-155.15%-1426.91%-4890.34%-15681.11%
FCF Margin
--89.78%-166.50%-317.56%-3260.10%-9038.08%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1.144.417.5822.02--